MedTrace Logo

AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation

NCT00560885 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2013-03-29

Study results available
· View outcomes & findings →

Summary

ABLATE is a prospective, non-randomized multi-center clinical trial to demonstrate the safety and effectiveness of the AtriCure Bipolar System for treating permanent atrial fibrillation during concomitant on-pump cardiac surgery.

Conditions

Interventions

DEVICE

AtriCure Bipolar System

Surgical bipolar radiofrequency ablation using the AtriCure Bipolar System

Sponsors & Collaborators

  • AtriCure, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2009-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00560885 on ClinicalTrials.gov